Skip to main content
logo
Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
20.57
+0.42 (2.08%)
Feb 6, 2026, 12:47 PM EST - Market open

Syndax Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
111.323.68--139.711.52
Revenue Growth (YoY)
595.65%---9109.56%-
Cost of Revenue
244.53242.47163.03118.5--
Gross Profit
-133.23-218.79-163.03-118.5139.711.52
Selling, General & Admin
167.44120.8866.9233.2625.2422.51
Research & Development
6.23---88.2550.44
Operating Expenses
173.67120.8866.9233.26113.4972.94
Operating Income
-306.9-339.67-229.95-151.7626.22-71.42
Interest Expense
-29-4.93-0.21-3.14-1.9-2.36
Interest & Investment Income
25.5126.0921.165.870.40.84
Other Non Operating Income (Expenses)
-1.19-0.25-0.36-0.320.2-0.22
Pretax Income
-311.58-318.76-209.36-149.3424.93-73.16
Net Income
-311.58-318.76-209.36-149.3424.93-73.16
Preferred Dividends & Other Adjustments
-----3.91
Net Income to Common
-311.58-318.76-209.36-149.3424.93-77.06
Shares Outstanding (Basic)
878670615241
Shares Outstanding (Diluted)
878670615441
Shares Change (YoY)
5.39%21.67%15.82%13.31%29.81%35.48%
EPS (Basic)
-3.60-3.72-2.98-2.460.48-1.87
EPS (Diluted)
-3.60-3.72-2.98-2.460.46-1.87
Free Cash Flow
-311.01-274.9-160.6-133.6829-71.26
Free Cash Flow Per Share
-3.59-3.21-2.28-2.200.54-1.73
Gross Margin
-119.70%---100.00%100.00%
Operating Margin
-275.73%-1434.43%--18.77%-4708.17%
Profit Margin
-279.93%-1346.11%--17.84%-5080.03%
Free Cash Flow Margin
-279.43%-1160.91%--20.76%-4697.43%
EBITDA
-306.9-339.66-229.94-151.7226.26-71.33
EBITDA Margin
-275.73%---18.80%-
D&A For EBITDA
00.010.010.030.040.09
EBIT
-306.9-339.67-229.95-151.7626.22-71.42
EBIT Margin
-275.73%---18.77%-
Revenue as Reported
111.323.68--139.711.52
Advertising Expenses
-7.36.11.5--
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q